Come Explore Dexcom at ADA 2026

Join Dexcom on the show floor to explore what’s new, what’s next and what personalized care can look like for you and your patients. Stop by booth #623 to see our portfolio in action, connect with our experts, and dive into our educational sessions focused on our innovations in diabetes and health & wellness. See you there! 

Discover the Dexcom Portfolio


US products
Explore Dexcom

Questions?

If you have any questions, please contact Dexcom at events@dexcom.com
Product and feature availability varies by country. *Results with Dexcom CGM have been proven in over 70 clinical studies, data available on clinicaltrials.gov. † Eligibility requirements must be met to try Dexcom G7 15 Day and Stelo. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.  BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. 

MAT-13836